West Pharmaceutical Services Inc. (NYSE:WST) – Investment analysts at Jefferies Group decreased their Q1 2018 EPS estimates for shares of West Pharmaceutical Services in a report issued on Thursday. Jefferies Group analyst D. Windley now anticipates that the medical instruments supplier will earn $0.64 per share for the quarter, down from their previous forecast of $0.66. Jefferies Group also issued estimates for West Pharmaceutical Services’ Q2 2018 earnings at $0.70 EPS, Q3 2018 earnings at $0.73 EPS and Q4 2018 earnings at $0.77 EPS.
West Pharmaceutical Services (NYSE:WST) last announced its earnings results on Thursday, February 15th. The medical instruments supplier reported $0.64 earnings per share for the quarter, topping the consensus estimate of $0.62 by $0.02. West Pharmaceutical Services had a net margin of 9.42% and a return on equity of 14.68%. The firm had revenue of $415.60 million for the quarter, compared to the consensus estimate of $416.90 million. During the same period in the prior year, the firm earned $0.54 EPS. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis.
Shares of West Pharmaceutical Services (NYSE WST) opened at $92.01 on Monday. West Pharmaceutical Services has a 52 week low of $77.97 and a 52 week high of $103.36. The firm has a market cap of $6,809.72, a P/E ratio of 46.23, a P/E/G ratio of 2.28 and a beta of 1.15. The company has a current ratio of 2.66, a quick ratio of 1.89 and a debt-to-equity ratio of 0.15.
West Pharmaceutical Services declared that its Board of Directors has initiated a stock repurchase plan on Thursday, February 15th that authorizes the company to repurchase 800,000 shares. This repurchase authorization authorizes the medical instruments supplier to buy shares of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s management believes its stock is undervalued.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 2nd. Shareholders of record on Wednesday, April 18th will be given a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.61%. The ex-dividend date of this dividend is Tuesday, April 17th. West Pharmaceutical Services’s dividend payout ratio is presently 28.14%.
Large investors have recently made changes to their positions in the business. ING Groep NV purchased a new stake in shares of West Pharmaceutical Services in the 4th quarter valued at approximately $249,000. Artisan Partners Limited Partnership purchased a new stake in shares of West Pharmaceutical Services in the 3rd quarter valued at approximately $81,059,000. High Pointe Capital Management LLC purchased a new stake in shares of West Pharmaceutical Services in the 4th quarter valued at approximately $308,000. Rhumbline Advisers increased its position in shares of West Pharmaceutical Services by 11.3% in the 3rd quarter. Rhumbline Advisers now owns 182,042 shares of the medical instruments supplier’s stock valued at $17,523,000 after purchasing an additional 18,477 shares during the last quarter. Finally, Public Employees Retirement System of Ohio boosted its holdings in shares of West Pharmaceutical Services by 52.5% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 50,788 shares of the medical instruments supplier’s stock valued at $4,889,000 after buying an additional 17,487 shares in the last quarter. 94.37% of the stock is currently owned by institutional investors.
COPYRIGHT VIOLATION WARNING: “Q1 2018 EPS Estimates for West Pharmaceutical Services Inc. Reduced by Analyst (WST)” was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this story on another domain, it was stolen and republished in violation of United States & international copyright & trademark laws. The correct version of this story can be accessed at https://sportsperspectives.com/2018/03/13/q1-2018-eps-estimates-for-west-pharmaceutical-services-inc-reduced-by-analyst-wst.html.
About West Pharmaceutical Services
West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.